Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 35

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 35
---
 |     |               | -- | % |
| David Rosenberg                              |     |              |   8,932 | -12 |     |           |   8,932 | -12 |     |                           | -- |     |               | -- | % |

| * | Less than one percent. |

| (1) | Beneficial                                                                                                                                     
 ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to shares of common        
 stock. Shares of common stock subject to options and warrants currently exercisable, or exercisable within 60 days, are counted as outstanding 
 for computing the percentage of the person holding such options or warrants but are not counted as outstanding for computing the percentage    
 of any other person. Substantially all of the warrants with respect to which the Warrant Shares included in the table may be issued are        
 subject to restrictions that prevent exercise to the extent that after the exercise the holder or its affiliates would beneficially own        
 in excess of 4.99% or 9.99% of the Company’s outstanding common stock.                                                                         |

<div align='center'>17</div>

| (2) | The amount and percentage of shares of our                                                       
 common stock that will be beneficially owned by the selling stockholders after completion        
 of the offering assume that they will sell all shares of our common stock being offered pursuant 
 to this prospectus.                                                                              |

| (3) | Based on 1,166,441 shares of our common stock                                                 
 issued and outstanding as of October 16, 2025. All shares of our common stock being offered   
 pursuant to this prospectus by a selling stockholder are counted as outstanding for computing 
 the percentage beneficial ownership of such selling stockholder.                              |

| (4) | Includes (i) 116,024 PIPE Shares, (ii) 188,390 Pre-Funded Warrant Shares and (iii) 608,828 Common                                   
 Warrant Shares. Antonio Ruiz-Gimenez has the power to vote or dispose of the securities reported herein that are held by ATW Master 
 Fund V LP. As a result, ATW Master Fund V LP and Antonio Ruiz-Gimenez may be deemed to have beneficial ownership of the securities  
 reported herein that are held by ATW Master Fund V LP. The address of ATW Master Fund V LP is 1 Pennsylvania Plaza, Suite 4810, New 
 York, NY 10119.                                                                                                                     |

| (5) | Includes (i)